Arcus Biosciences (RCUS) Change in Cash (2017 - 2026)

Arcus Biosciences' Change in Cash history runs 10 years deep, the most recent figure standing at -$21.0 million for Q1 2026.

• In Q1 2026, Change in Cash fell 150.0% year-over-year to -$21.0 million; the TTM figure through Mar 2026 stood at $9.0 million (up 28.57% YoY), while the FY2025 annual figure was $72.0 million, up 213.04% from the prior year.
• Change in Cash for Q1 2026 stood at -$21.0 million, down from -$16.0 million in the prior quarter.
• The five-year high for Change in Cash was $401.0 million in Q1 2022, with the low at -$276.0 million in Q2 2022.
• The 5-year median for Change in Cash is -$12.0 million (2022), against an average of $3.1 million.
• The sharpest annual moves came in 2023 and 2025: Change in Cash slumped 375.0% in 2023, then surged 293.1% in 2025.
• Arcus Biosciences' Change in Cash stood at -$12.0 million in 2022, then plunged by 375.0% to -$57.0 million in 2023, then advanced by 10.53% to -$51.0 million in 2024, then surged by 68.63% to -$16.0 million in 2025, then plunged by 31.25% to -$21.0 million in 2026.
• Business Quant data shows RCUS's Change in Cash at -$21.0 million in Q1 2026, -$16.0 million in Q4 2025, and -$10.0 million in Q3 2025.